RBC Capital Maintains Outperform on Verastem, Lowers Price Target to $16

Benzinga · 05/28 12:11
RBC Capital analyst Gregory Renza maintains Verastem (NASDAQ:VSTM) with a Outperform and lowers the price target from $32 to $16.